Rallybio Corp (RLYB) SEC Filings & Financial Intelligence
Rallybio Corp (RLYB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RLYB
CIK: 1739410
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerChristopher Smith
Audit LocationHartford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 425 | 2026-11-06 | — | 425 | 0001193125-26-452121 | View SEC Doc Filr Page |
| 8-K | 2026-11-06 | 2026-11-06 | 8-K | 0001193125-26-452115 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-04 | 4 | 0001193125-26-450103 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-04 | 4 | 0001193125-26-450102 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001193125-26-447550 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-02 | 4 | 0001193125-26-445701 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-29 | 4 | 0001193125-26-443915 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-29 | 4 | 0001193125-26-443898 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-28 | 4 | 0001193125-26-441964 | View SEC Doc Filr Page |
| 4 | 2026-10-29 | 2026-10-27 | 4 | 0001193125-26-438086 | View SEC Doc Filr Page |
| 4 | 2026-10-28 | 2026-10-26 | 4 | 0001193125-26-436314 | View SEC Doc Filr Page |
| 4 | 2026-10-28 | 2026-10-26 | 4 | 0001193125-26-436313 | View SEC Doc Filr Page |
| 10-Q | 2026-10-27 | 2026-09-30 | 10-Q | 0001628280-26-067422 | View SEC Doc Filr Page |
| 425 | 2026-10-26 | — | 425 | 0001193125-26-432123 | View SEC Doc Filr Page |
| 8-K | 2026-10-26 | 2026-10-25 | 8-K | 0001193125-26-432114 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-16 | 4 | 0001193125-26-426875 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-16 | 4 | 0001193125-26-426872 | View SEC Doc Filr Page |
| EFFECT | 2026-10-15 | — | EFFECT Filing | 9999999995-26-003252 | View SEC Doc Filr Page |
| 424B3 | 2026-10-15 | — | 424B3 | 0001193125-26-422924 | View SEC Doc Filr Page |
| S-4/A | 2026-10-14 | — | S-4/A NO. 4 | 0001193125-26-421809 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-12 | 4 | 0001193125-26-421747 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-09 | 4 | 0001193125-26-420562 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-418051 | View SEC Doc Filr Page |
| S-4/A | 2026-10-05 | — | S-4/A NO. 3 | 0001193125-26-412774 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001193125-26-410885 | View SEC Doc Filr Page |